» Articles » PMID: 33870030

Fluorescence Artifact Correction in the Thrombin Generation Assay: Necessity for Correction Algorithms in Procoagulant Samples

Overview
Publisher Elsevier
Date 2021 Apr 19
PMID 33870030
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The thrombin generation (TG) test is a global hemostasis assay sensitive to procoagulant conditions. However, some TG assays may underestimate elevated TG when the thrombin fluorogenic substrate is depleted or fluorescence is attenuated by the inner filter effect (IFE).

Objectives: We sought to elucidate the extent to which procoagulant conditions require correcting for fluorogenic substrate depletion and/or IFE.

Methods: We analyzed corrections for substrate depletion and IFE and their effect on TG parameters in plasma samples with elevated blood coagulation factors in the presence or absence of thrombomodulin via commercial calibrated automated thrombogram (CAT) platform and in-house software capable of internal thrombin calibration with or without CAT-like artifact correction.

Results: Elevated thrombin peak height (TPH) and endogenous thrombin potential (ETP) were detected with 2× and 4× increases in blood coagulation factors I, V, VIII, IX, X, and XI, or prothrombin in the presence or absence of artifact correction. The effect of the CAT algorithm was evident in TG curves from both low procoagulant (thrombomodulin-supplemented) and procoagulant (factor-supplemented) plasma samples. However, in all samples, with the exception of elevated prothrombin, CAT's correction was small (<10%) and did not affect detection of procoagulant samples versus normal plasma. For elevated prothrombin samples, uncorrected TPH or ETP values were underestimated, and CAT correction produced drastically elevated TG curves.

Conclusions: Our data suggest that correction for substrate consumption and IFE, as offered by the CAT algorithm, is critical for detecting a subset of extremely procoagulant samples, such as elevated prothrombin, but is not necessary for all other conditions, including elevated factors XI and VIII.

Citing Articles

Single-Particle Plasmon Sensor to Monitor Proteolytic Activity in Real Time.

Oliveira-Silva R, Wang Y, Nooteboom S, Prazeres D, Paulo P, Zijlstra P ACS Appl Opt Mater. 2023; 1(10):1661-1669.

PMID: 37915971 PMC: 10616847. DOI: 10.1021/acsaom.3c00226.


Sources of bias and limitations of thrombinography: inner filter effect and substrate depletion at the edge of failure algorithm.

Jackson J, Longstaff C, Woodle S, Chang W, Ovanesov M Thromb J. 2023; 21(1):104.

PMID: 37794418 PMC: 10548689. DOI: 10.1186/s12959-023-00549-5.

References
1.
Mann K, Brummel K, Butenas S . What is all that thrombin for?. J Thromb Haemost. 2003; 1(7):1504-14. DOI: 10.1046/j.1538-7836.2003.00298.x. View

2.
Lippi G, Pasalic L, Favaloro E . Detection of mild inherited disorders of blood coagulation: current options and personal recommendations. Expert Rev Hematol. 2015; 8(4):527-42. DOI: 10.1586/17474086.2015.1039978. View

3.
Hillarp A, Baghaei F, Fagerberg Blixter I, Gustafsson K, Stigendal L, Sten-Linder M . Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays. J Thromb Haemost. 2010; 9(1):133-9. DOI: 10.1111/j.1538-7836.2010.04098.x. View

4.
Machlus K, Colby E, Wu J, Koch G, Key N, Wolberg A . Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram. Thromb Haemost. 2009; 102(5):936-44. PMC: 2904819. DOI: 10.1160/TH09-03-0180. View

5.
Hemker H, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R . Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb. 2003; 33(1):4-15. DOI: 10.1159/000071636. View